Perspective Therapeutics Inc (CATX)
3.00
-3.17
(-51.38%)
USD |
NYAM |
Nov 21, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
Perspective Therapeutics Net Income (Quarterly): -15.12M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -15.12M |
| June 30, 2024 | -11.70M |
| March 31, 2024 | -12.28M |
| December 31, 2023 | -24.68M |
| September 30, 2023 | -10.36M |
| June 30, 2023 | -11.11M |
| March 31, 2023 | -0.371M |
| September 30, 2022 | -4.068M |
| June 30, 2022 | -2.078M |
| March 31, 2022 | -1.347M |
| December 31, 2021 | -1.604M |
| September 30, 2021 | -2.243M |
| June 30, 2021 | -1.061M |
| March 31, 2021 | -0.745M |
| December 31, 2020 | -0.868M |
| September 30, 2020 | -0.713M |
| June 30, 2020 | -1.188M |
| March 31, 2020 | -0.545M |
| December 31, 2019 | -0.897M |
| September 30, 2019 | -0.816M |
| June 30, 2019 | -1.095M |
| March 31, 2019 | -1.127M |
| December 31, 2018 | -1.414M |
| September 30, 2018 | -1.508M |
| June 30, 2018 | -2.358M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.332M |
| December 31, 2017 | -1.463M |
| September 30, 2017 | -1.546M |
| June 30, 2017 | -1.855M |
| March 31, 2017 | -1.36M |
| December 31, 2016 | -1.45M |
| September 30, 2016 | -1.498M |
| June 30, 2016 | -1.185M |
| March 31, 2016 | -1.195M |
| December 31, 2015 | -1.311M |
| September 30, 2015 | -1.02M |
| June 30, 2015 | -1.035M |
| March 31, 2015 | -0.9536M |
| December 31, 2014 | -0.907M |
| September 30, 2014 | -0.7859M |
| June 30, 2014 | -1.678M |
| March 31, 2014 | -2.083M |
| December 31, 2013 | -0.927M |
| September 30, 2013 | -1.271M |
| June 30, 2013 | -0.9936M |
| March 31, 2013 | -0.715M |
| December 31, 2012 | -1.154M |
| September 30, 2012 | -0.9937M |
| June 30, 2012 | -1.205M |
| March 31, 2012 | -0.5529M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-24.68M
Minimum
Dec 2023
-0.371M
Maximum
Mar 2023
-5.420M
Average
-1.604M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Plus Therapeutics Inc | -2.874M |
| Retractable Technologies Inc | -1.922M |
| InfuSystems Holdings Inc | 1.807M |
| Xtant Medical Holdings Inc | -5.024M |
| Catheter Precision Inc | -4.12M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 18.63M |
| EPS Diluted (Quarterly) | -0.21 |
| Enterprise Value | -63.40M |
| Earnings Yield | -48.67% |
| Normalized Earnings Yield | -20.00 |